Cann Group Issues 527,100 Unquoted Convertible Notes

Cann Group ( (AU:CAN) ) has issued an announcement.

Cann Group Limited has notified the market of the issue of 527,100 unquoted convertible notes, with the securities formally issued on 18 March 2026. The notes form part of a previously disclosed transaction and are not intended to be quoted on the ASX, indicating the company is using unlisted convertible instruments as a funding or capital management tool without immediate dilution in its quoted equity.

The move underscores Cann Group’s continued use of structured financing to support its operations and growth plans in the medical cannabis industry. For existing stakeholders, the unquoted nature of the convertible notes means potential future equity conversion without direct impact on current trading liquidity, while still expanding the company’s funding base.

The most recent analyst rating on (AU:CAN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Cann Group stock, see the AU:CAN Stock Forecast page.

More about Cann Group

Cann Group Limited is an Australian-listed company in the medical cannabis sector. It develops and supplies cannabis-based products for therapeutic use, operating within a regulated market and targeting growing demand for medicinal cannabis in Australia and potentially abroad.

Average Trading Volume: 12,112,118

Technical Sentiment Signal: Sell

Current Market Cap: A$11.12M

For a thorough assessment of CAN stock, go to TipRanks’ Stock Analysis page.